CVS CEO Merlo gets personal with new data-driven healthcare model in Aetna merger

Sept. 21, 2018

CVS Health’s $69 billion merger with health insurer Aetna will create a new data-driven healthcare model that’s more personal, convenient, and tailored to individual patients than ever before, CVS CEO Larry Merlo said.

Merlo is, in a way, disrupting and rewriting the business model for his drugstore chain before someone else does.

Announced in December, the deal is awaiting antitrust approval from the Department of Justice. The company expects it to close at the beginning of the fourth quarter.

The healthcare industry is ripe for change, with consumers frustrated with rising costs and new entrants eyeing an opportunity to upend established practices. Amazon bought its way into the prescription drug space earlier this year with its acquisition of PillPack, a company that organizes and ships packages of medications to patients.

Without calling out Amazon or PillPack by name, Merlo touted CVS’ superior customer service. He was speaking to business and community leaders at Town Hall, a civic forum in Los Angeles.

CVS already provides in-home infusion services for customers, allows people to refill prescriptions through an app and pick them up at one of its nearly 10,000 stores and delivers medication directly to patient’s homes with an electronic prescription from their doctor, he said.

In combining CVS and Aetna, Merlo said they’ll create a model that’s “easier to use, less expensive and puts people at the center of their care.” The company will focus on three pillars: Making healthcare local and simple and improving health.

Nearly 70% of Americans live within three miles of a CVS pharmacy, he said. With that in mind, the combined company can offer many options for people to access care, whether at CVS’ stores and MinuteClinics, their homes or through digital services.

CVS and Aetna can coordinate patients’ care, Merlo said, hinting the combined company may work with hospitals and physicians’ electronic medical records to help patients understand and execute their care plans.

In terms of costs, the combined company will have more data, giving CVS a more complete picture of someone’s health, Merlo said. That will allow the company to better predict who might develop diabetes and provide customers with preventive counseling, educate people with diabetes on how to lose weight and eat better, as well as help patients monitor blood glucose levels with text messages that alert them when the results look concerning.

CNBC has the full story

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?